Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study

Akgun, Zuleyha; Saglam, Sezer; Yucel, Serap; Gural, Zeynep; Balik, Emre; Cipe, Gokhan; YILDIZ, ŞEYMA; Kilickap, Sadettin; Okyar, Alper; Kaytan-Saglam, Esra

doi:10.1007/s00280-014-2558-x

Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen study

Atıf İçin Kopyala

Akgun Z., Saglam S., Yucel S. , Gural Z. , Balik E., Cipe G., et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY, cilt.74, ss.751-756, 2014 (SCI İndekslerine Giren Dergi)

Cilt numarası: 74 Konu: 4
Basım Tarihi: 2014
Doi Numarası: 10.1007/s00280-014-2558-x
Dergi Adı: CANCER CHEMOTHERAPY AND PHARMACOLOGY
Sayfa Sayısı: ss.751-756

Özet

The aim of this study was to evaluate efficacy and safety of chronomodulated capecitabine administered according to a specific time schedule (Brunch Regimen: Breakfast and Lunch) as a part of neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.